| scholarly article | Q13442814 |
| P2093 | author name string | Logroscino G | |
| Bromfield EB | |||
| Hurwitz S | |||
| Rossetti AO | |||
| P2860 | cites work | Assessment of acute morbidity and mortality in nonconvulsive status epilepticus | Q30311928 |
| The biochemical basis and pathophysiology of status epilepticus | Q30454139 | ||
| Pathophysiology of status epilepticus. | Q30464084 | ||
| Evidence against permanent neurologic damage from nonconvulsive status epilepticus | Q33729401 | ||
| No, some types of nonconvulsive status epilepticus cause little permanent neurologic sequelae (or: "the cure may be worse than the disease"). | Q34147041 | ||
| Propofol treatment of refractory status epilepticus: a study of 31 episodes | Q34330637 | ||
| Diagnosis and treatment of nonconvulsive status epilepticus | Q34458400 | ||
| Is it status? | Q34680713 | ||
| Status epilepticus on the intensive care unit | Q35109754 | ||
| Incidence and short-term prognosis of status epilepticus in adults in Bologna, Italy | Q35161341 | ||
| The management of refractory generalised convulsive and complex partial status epilepticus in three European countries: a survey among epileptologists and critical care neurologists | Q35475202 | ||
| A systematic review of the epidemiology of status epilepticus. | Q36018491 | ||
| Electroclinical features of status epilepticus | Q40414093 | ||
| Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus | Q43747004 | ||
| Nonconvulsive status epilepticus in adults: thirty-two consecutive patients from a general hospital population | Q43876599 | ||
| Refractory status epilepticus: frequency, risk factors, and impact on outcome | Q43885520 | ||
| A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia | Q44155514 | ||
| Determinants of mortality in status epilepticus | Q45088732 | ||
| It's time to revise the definition of status epilepticus | Q46722956 | ||
| Refractory status epilepticus: effect of treatment aggressiveness on prognosis | Q46802749 | ||
| Incidence of status epilepticus in adults in Germany: a prospective, population-based study | Q47620704 | ||
| Incidence of status epilepticus in French-speaking Switzerland: (EPISTAR). | Q50664700 | ||
| Short-term mortality after a first episode of status epilepticus. | Q50890491 | ||
| Incidence of status epilepticus in Rochester, Minnesota, 1965-1984. | Q50899694 | ||
| Generalized tonic-clonic status epilepticus: causes, treatment, complications and predictors of case fatality. | Q51497276 | ||
| Nonconvulsive status epilepticus in the emergency room. | Q51568437 | ||
| Complex partial status epilepticus accompanied by serious morbidity and mortality. | Q52052126 | ||
| Survey of management of first-ever seizures in a hospital based community. | Q53601213 | ||
| Guidelines for Epidemiologic Studies on Epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy | Q53980075 | ||
| Status Epilepticus | Q59664579 | ||
| Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus | Q72856183 | ||
| Predictors of functional disability and mortality after status epilepticus | Q77462062 | ||
| Nonconvulsive status epilepticus in the critically ill elderly | Q77578842 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | consciousness | Q7087 |
| status epilepticus | Q980709 | ||
| P304 | page(s) | 611-615 | |
| P577 | publication date | 2006-05-01 | |
| P1433 | published in | Journal of Neurology, Neurosurgery and Psychiatry | Q1599804 |
| P1476 | title | Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation | |
| P478 | volume | 77 |
| Q47116651 | A Study of Super Refractory Status Epilepticus from India |
| Q43280977 | A clinical, radiological and outcome study of status epilepticus from India |
| Q41669926 | A one-year prospective study of refractory status epilepticus in Modena, Italy. |
| Q36904418 | Acute confusion or altered mental state: consider nonconvulsive status epilepticus |
| Q35235276 | Age-dependent sex difference of the incidence and mortality of status epilepticus: a twelve year nationwide population-based cohort study in Taiwan |
| Q47731492 | An update on the recognition and treatment of non-convulsive status epilepticus in the intensive care unit |
| Q37623219 | Anesthetic drugs in status epilepticus: risk or rescue? A 6-year cohort study. |
| Q50905482 | Antibody-mediated status epilepticus: a retrospective multicenter survey. |
| Q40150721 | Association of seizure duration and outcome in refractory status epilepticus |
| Q45988094 | Benzodiazepine overtreatment in status epilepticus is related to higher need of intubation and longer hospitalization. |
| Q34297433 | Causes of status epilepticus |
| Q40956650 | Cerebrospinal fluid tau proteins in status epilepticus. |
| Q36931970 | Characteristics and role in outcome prediction of continuous EEG after status epilepticus: A prospective observational cohort |
| Q91257798 | Comment regarding: "Predictors of long-term mortality in status epilepticus" |
| Q86093114 | Comments on Maganti R et al. Nonconvulsive status epilepticus. Epilepsy & behavior 2008;12:572-586 |
| Q58116789 | Cost of status epilepticus (SE): Effects of delayed treatment and SE duration |
| Q90285984 | Critical Care Management of Status Epilepticus at a Tertiary Care University Hospital |
| Q41990561 | Delays and Factors Related to Cessation of Generalized Convulsive Status Epilepticus |
| Q61451955 | Determinants of Outcome in Convulsive Status Epilepticus in Adults: An Ambispective Study from Central India |
| Q54235014 | Does semiology of status epilepticus have an impact on treatment response and outcome? |
| Q92916622 | Duration of therapeutic coma and outcome of refractory status epilepticus |
| Q28821401 | Effects of clobazam for treatment of refractory status epilepticus |
| Q39208909 | Efficacy of sublingual lorazepam versus intrarectal diazepam for prolonged convulsions in Sub-Saharan Africa |
| Q38599756 | Emergency Neurological Life Support: Status Epilepticus |
| Q50075797 | Emergency Neurological Life Support: Status Epilepticus |
| Q38041474 | Emergency neurological life support: status epilepticus |
| Q39095720 | Epidemiology-based mortality score in status epilepticus (EMSE). |
| Q93147683 | Etiology and outcomes of convulsive status epilepticus in children |
| Q89288099 | Evaluation of STESS, mRSTESS, and EMSE to Predict High Disability and Mortality at Hospital Discharge in Ecuadorian Patients with Status Epilepticus |
| Q36909082 | Evaluation of a clinical tool for early etiology identification in status epilepticus. |
| Q53608555 | Extended EEG and non-convulsive status epilepticus: Benefit over routine EEG? |
| Q42926144 | Generalized convulsive status epilepticus management in adults: A cohort study with evaluation of professional practice |
| Q38546454 | Grand Rounds: An Update on Convulsive Status Epilepticus. |
| Q38004984 | Guidelines for the evaluation and management of status epilepticus |
| Q36620651 | Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application. |
| Q59336095 | Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus |
| Q39829457 | Impact of treatment on the short-term prognosis of status epilepticus in two population-based cohorts |
| Q96111202 | Improving the ability to predict hospital mortality among adults by combining two status epilepticus outcome scoring tools |
| Q40951937 | Incidences and outcomes of status epilepticus: A 9-year longitudinal national study |
| Q30278847 | Intravenous anesthesia in treatment of nonconvulsive status epilepticus: Characteristics and outcomes |
| Q88664922 | Intravenous lacosamide (LCM) in status epilepticus (SE): Weight-adjusted dose and efficacy |
| Q38978982 | Is intravenous lorazepam really more effective and safe than intravenous diazepam as first-line treatment for convulsive status epilepticus? A systematic review with meta-analysis of randomized controlled trials |
| Q90949065 | Lessons from the Established Status Epilepticus Treatment Trial |
| Q91628567 | Levetiracetam circulating concentrations and response in status epilepticus |
| Q27028089 | Management of refractory status epilepticus in adults: still more questions than answers |
| Q44750565 | Management of status epilepticus in neurological versus medical intensive care unit: does it matter? |
| Q26748926 | Managing Status Epilepticus in the Older Adult |
| Q26744214 | Neuroprotective effect of therapeutic hypothermia versus standard care alone after convulsive status epilepticus: protocol of the multicentre randomised controlled trial HYBERNATUS |
| Q88185388 | Newer Antiepileptic Drugs for Status Epilepticus in Adults: What's the Evidence? |
| Q38880476 | Newer Antiepileptic Drugs in Status Epilepticus: Prescription Trends and Outcomes in Comparison with Traditional Agents |
| Q83821995 | Newer antiepileptic drugs in the treatment of status epilepticus: impact on prognosis |
| Q51177955 | Outcome predictors for status epilepticus--what really counts. |
| Q58929260 | Outcomes in 140 critically ill patients with status epilepticus |
| Q41494364 | Outcomes of patients with altered level of consciousness and abnormal electroencephalogram: A retrospective cohort study. |
| Q36927224 | Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: A multicenter comparison. |
| Q27005774 | Predicting outcome of status epilepticus |
| Q27339565 | Prediction of functional outcome in patients with convulsive status epilepticus: the END-IT score |
| Q40335175 | Predictive Value of Short-Term EEG Recording in Critically ill Adult Patients |
| Q34153257 | Predictors for good functional outcome after neurocritical care |
| Q39041815 | Predictors of Outcome of Convulsive Status Epilepticus Among an Egyptian Pediatric Tertiary Hospital |
| Q37717552 | Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study |
| Q40060185 | Predictors of outcomes and refractoriness in status epilepticus: A prospective study |
| Q33444384 | Predictors of refractoriness in a Turkish status epilepticus data bank |
| Q37957128 | Problems and controversies in status epilepticus: a review and recommendations |
| Q33942135 | Prognosis and therapy of tumor-related versus non-tumor-related status epilepticus: a systematic review and meta-analysis. |
| Q48249067 | Prognosis of status epilepticus in elderly patients |
| Q37800260 | Prognostic factors, morbidity and mortality in tonic–clonic status epilepticus: A review |
| Q37000111 | Recent developments in the diagnosis and treatment of status epilepticus |
| Q41593492 | Recurrence of status epilepticus: prognostic role and outcome predictors |
| Q40799423 | Refractory and super-refractory status epilepticus in adults: a 9-year cohort study |
| Q38040546 | Requirement for cardiac telemetry during intravenous phenytoin infusion: guideline fact or guideline fiction? |
| Q36873527 | Seizure-related injury and death |
| Q37180564 | Seizures and reproductive function: insights from female rats with epilepsy |
| Q46390833 | Status Epilepticus Severity Score (STESS): a tool to orient early treatment strategy |
| Q37288222 | Status epilepticus: Using antioxidant agents as alternative therapies. |
| Q44385351 | Status epilepticus: clinical presentation, cause, outcome, and predictors of death in 119 Ethiopian patients |
| Q40171908 | Study of Refractory Status Epilepticus from a Tertiary Care Center |
| Q48958797 | Subsequent Bilateral Hippocampal Diffusion Restriction and Atrophy in Repeated Status Epilepticus |
| Q84761207 | Survivors and nonsurvivors of very prolonged status epilepticus |
| Q47261977 | The Clinical Characteristics and Prognostic Analysis of Status Epilepticus in Northeast China |
| Q45904186 | The Clinical Features and Prognosis of Patients With Nonconvulsive Status Epilepticus in the Neurological Intensive Care Unit of a Tertiary Referral Center in Turkey. |
| Q64260585 | The Different Clinical Features Between Autoimmune and Infectious Status Epilepticus |
| Q37106036 | The epidemiology of convulsive and nonconvulsive status epilepticus |
| Q87275214 | The epidemiology of status epilepticus in the United States |
| Q90098557 | The etiology and prognosis of super-refractory convulsive status epilepticus in children |
| Q37106012 | The surgical treatment of status epilepticus |
| Q38334273 | Therapeutic choices in convulsive status epilepticus |
| Q38028609 | Topiramate as an adjunctive treatment in patients with refractory status epilepticus: an observational cohort study. |
| Q84814960 | Treatment deviating from guidelines does not influence status epilepticus prognosis |
| Q89160827 | Treatment of Refractory and Super-refractory Status Epilepticus |
| Q34619042 | Treatment of convulsive status epilepticus |
| Q83462024 | Treatment of status epilepticus in a large community hospital |
| Q37106001 | Which anesthetic should be used in the treatment of refractory status epilepticus? |
| Q50645599 | YouTube as a potential learning tool to help distinguish tonic-clonic seizures from nonepileptic attacks. |
Search more.